Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 62 articles: HTML format

Single Articles

May 2026
1. DOOKIE R, Narciso AR, Gaytan MO, Narayana Moorthy A, et al
   Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization.
   Proc Natl Acad Sci U S A. 2026;123:e2537226123.
   PubMed     Abstract available
   
   
   
2. XIAO Z, Xu H, Ma N, Lei L, et al
   A BCG hydrogel enables localized NOD2/STING activation to overcome resistance to immune checkpoint blockade.
   Proc Natl Acad Sci U S A. 2026;123:e2531588123.
   PubMed     Abstract available
   
   
   
3. ZHANG J, Zhang X, Yao Y, Zhou J, et al
   Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.
   Proc Natl Acad Sci U S A. 2026;123:e2517814123.
   PubMed     Abstract available
   
   
   
4. GAYTAN MO, Dookie RS, Chakraborty S, Narayana Moorthy A, et al
   Identification of immunostimulatory antigens in Group A Streptococcus-derived vesicles.
   Proc Natl Acad Sci U S A. 2026;123:e2537351123.
   PubMed     Abstract available
   
   
   
5. HUANG KA, Nguyen HTV, Chen YY, Wu KJ, et al
   Broad neutralization of influenza B hemagglutinin antibodies via receptor mimicry and glycan engagement.
   Proc Natl Acad Sci U S A. 2026;123:e2532989123.
   PubMed     Abstract available
   
   
   
6. ZHANG Y, Wang C, Zheng Y, Chen F, et al
   An Ad5-vectored platform generating self-assembling VLPs elicits potent mucosal immunity against influenza A virus and SARS-CoV-2.
   Proc Natl Acad Sci U S A. 2026;123:e2519857123.
   PubMed     Abstract available
   
   
   
7. HABIB R, Solieva SO, Lin ZJ, Ghosh S, et al
   Deep mining of the human antibody repertoire identifies frequent and genetically diverse CDRH3 topologies targetable by vaccination.
   Proc Natl Acad Sci U S A. 2026;123:e2532810123.
   PubMed     Abstract available
   
   
   April 2026
8. WELLS CR, Pandey A, Ye Y, Bawden C, et al
   The health and economic repercussions of declining MMR coverage in the United States.
   Proc Natl Acad Sci U S A. 2026;123:e2605971123.
   PubMed     Abstract available
   
   
   
9. GUO S, Lei Q, Chen Y, Yang J, et al
   Oocyte-inspired universal whole-cell vaccines against tumor heterogeneity.
   Proc Natl Acad Sci U S A. 2026;123:e2520276123.
   PubMed     Abstract available
   
   
   March 2026
10. 
    Correction for Te et al., Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage.
    Proc Natl Acad Sci U S A. 2026;123:e2607878123.
    PubMed    
    
    
    
11. FU C, Ma T, Clausen BE, Mellman I, et al
    Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity.
    Proc Natl Acad Sci U S A. 2026;123:e2518080123.
    PubMed     Abstract available
    
    
    January 2026
12. TE N, Chin AWH, Gu H, Zhirong Jia J, et al
    Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage.
    Proc Natl Acad Sci U S A. 2026;123:e2518645123.
    PubMed     Abstract available
    
    
    
13. GERVAIS A, Bastard P, Zhang Q, Jaffar-Bandjee MC, et al
    Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.
    Proc Natl Acad Sci U S A. 2026;123:e2532212123.
    PubMed     Abstract available
    
    
    
14. WIATR M, Wang Z, Canis M, Hernandez B, et al
    Memory B cell development in response to mRNA SARS-CoV-2 and nanoparticle immunization in mice.
    Proc Natl Acad Sci U S A. 2026;123:e2527869123.
    PubMed     Abstract available
    
    
    December 2025
15. GLEASON A, Impalli I, Sheen J, Cabezas Murillo A, et al
    Global vaccination coverage and disease incidence in cattle, pigs, and poultry.
    Proc Natl Acad Sci U S A. 2025;122:e2515557122.
    PubMed     Abstract available
    
    
    
16. CAPUCETTI A, Falivene J, Pizzichetti C, Latino I, et al
    Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2510392122.
    PubMed     Abstract available
    
    
    
17. JAMIESON KH, Gibson LA, Jamieson PE, Patterson S Jr, et al
    Using a mental model approach to undercut the effects of exposure to mRNA vaccination misconceptions: Two randomized trials.
    Proc Natl Acad Sci U S A. 2025;122:e2517067122.
    PubMed     Abstract available
    
    
    November 2025
18. BI K, Bandekar SR, Bouchnita A, Cramer A, et al
    Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States.
    Proc Natl Acad Sci U S A. 2025;122:e2505175122.
    PubMed     Abstract available
    
    
    
19. SONG K, Nguyen DC, Wang Y, Jokonya S, et al
    Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses.
    Proc Natl Acad Sci U S A. 2025;122:e2409978122.
    PubMed     Abstract available
    
    
    
20. CHO E, Davis MA, Nowak JA, Izzo M, et al
    Modulating antigen processing through metal-organic frameworks to bias adaptive immunity.
    Proc Natl Acad Sci U S A. 2025;122:e2409555122.
    PubMed     Abstract available
    
    
    
21. TATARA AM, Lightbown S, Kang S, Jung WH, et al
    Scaffold vaccination for prevention of orthopedic device infection.
    Proc Natl Acad Sci U S A. 2025;122:e2409562122.
    PubMed     Abstract available
    
    
    
22. HAAS CM, Jasti N, Dosey A, Allen JD, et al
    From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks.
    Proc Natl Acad Sci U S A. 2025;122:e2409566122.
    PubMed     Abstract available
    
    
    
23. WAGNER AA, Herrera DP, Rudder AL, Kinsey C, et al
    Accessing robust vaccine coformulation stability by single adjuvant detection on a microelectrode.
    Proc Natl Acad Sci U S A. 2025;122:e2522044122.
    PubMed     Abstract available
    
    
    October 2025
24. 
    Correction to Supporting Information for Milkman et al., A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2025;122:e2527439122.
    PubMed    
    
    
    
25. LV H, Teo QW, Pholcharee T, Liu W, et al
    Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.
    Proc Natl Acad Sci U S A. 2025;122:e2510927122.
    PubMed     Abstract available
    
    
    September 2025
26. REUBER EE, Hickey E, Pradhan A, Sprute R, et al
    Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development.
    Proc Natl Acad Sci U S A. 2025;122:e2505340122.
    PubMed     Abstract available
    
    
    
27. MORIYAMA M, Rodrigues G, Wang J, Jayewickreme R, et al
    Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice.
    Proc Natl Acad Sci U S A. 2025;122:e2422171122.
    PubMed     Abstract available
    
    
    
28. VILLAREJO-TORRES M, Nombela-Diaz I, Munoz-Santos D, Ruiz-Yuste M, et al
    SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
    Proc Natl Acad Sci U S A. 2025;122:e2516587122.
    PubMed     Abstract available
    
    
    
29. SWINGLE KL, Hamilton AG, Han X, Liao KC, et al
    Circular RNA lipid nanoparticle vaccine against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2025;122:e2505718122.
    PubMed     Abstract available
    
    
    
30. WANG S, Sun H, Wang Y, Wang Z, et al
    Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.
    Proc Natl Acad Sci U S A. 2025;122:e2503254122.
    PubMed     Abstract available
    
    
    August 2025
31. LIN X, Cottrell CA, Kalyuzhniy O, Tingle R, et al
    Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.
    Proc Natl Acad Sci U S A. 2025;122:e2510163122.
    PubMed     Abstract available
    
    
    
32. HSU CC, Chamblee M, Ye C, Shamseldin MM, et al
    Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.
    Proc Natl Acad Sci U S A. 2025;122:e2506821122.
    PubMed     Abstract available
    
    
    
33. MCGUIRE DJ, Akondy RS, Yang S, Edupuganti S, et al
    Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.
    Proc Natl Acad Sci U S A. 2025;122:e2322982122.
    PubMed     Abstract available
    
    
    July 2025
34. RIDELFI M, Vezzani G, Roscioli E, Batani G, et al
    A multifunctional anti-O-Antigen human monoclonal antibody protects against Shigella sonnei infection in vivo.
    Proc Natl Acad Sci U S A. 2025;122:e2426211122.
    PubMed     Abstract available
    
    
    May 2025
35. WINHEIM E, Santos-Peral A, Ehm T, Rinke L, et al
    Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses.
    Proc Natl Acad Sci U S A. 2025;122:e2422236122.
    PubMed     Abstract available
    
    
    April 2025
36. RADIC L, Offersgaard A, Kadava T, Zon I, et al
    Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.
    Proc Natl Acad Sci U S A. 2025;122:e2420402122.
    PubMed     Abstract available
    
    
    March 2025
37. GAILLETON R, Mathew NR, Reusch L, Schon K, et al
    Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2421724122.
    PubMed     Abstract available
    
    
    
38. 
    Correction for Chen et al., Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.
    Proc Natl Acad Sci U S A. 2025;122:e2502986122.
    PubMed    
    
    
    
39. TORGBOR C, Sohn H, Dizon BLP, Mutic EC, et al
    In the activation of HPV-specific human B cells HPV-VLP vaccines mimic membrane-associated antigens.
    Proc Natl Acad Sci U S A. 2025;122:e2414514122.
    PubMed     Abstract available
    
    
    February 2025
40. NGUYEN YTK, Zhu X, Han J, Rodriguez AJ, et al
    Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.
    Proc Natl Acad Sci U S A. 2025;122:e2416628122.
    PubMed     Abstract available
    
    
    January 2025
41. 
    Correction for Mehmood et al., Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
    Proc Natl Acad Sci U S A. 2025;122:e2424809121.
    PubMed    
    
    
    December 2024
42. MEHRA S, Nosten F, Luxemburger C, White NJ, et al
    Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial.
    Proc Natl Acad Sci U S A. 2024;121:e2401024121.
    PubMed     Abstract available
    
    
    
43. ABT ER, Lam AK, Noguchi M, Rashid K, et al
    Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
    Proc Natl Acad Sci U S A. 2024;121:e2406332121.
    PubMed     Abstract available
    
    
    November 2024
44. MEHMOOD S, Naseer S, Chen DL
    Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
    Proc Natl Acad Sci U S A. 2024;121:e2406034121.
    PubMed     Abstract available
    
    
    
45. SOBRAL MC, Cabizzosu L, Kang SJ, Ruark K, et al
    IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2322356121.
    PubMed     Abstract available
    
    
    
46. LOOMIS RJ, Lai YT, Sowers SB, Fisher B, et al
    Structure-based design of glycoprotein subunit vaccines for mumps.
    Proc Natl Acad Sci U S A. 2024;121:e2404053121.
    PubMed     Abstract available
    
    
    October 2024
47. WAN J, Wang C, Wang Z, Wang L, et al
    CXCL13 promotes broad immune responses induced by circular RNA vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2406434121.
    PubMed     Abstract available
    
    
    
48. PARK SW, Lawal T, Marin M, Marlow MA, et al
    Modeling the population-level impact of a third dose of MMR vaccine on a mumps outbreak at the University of Iowa.
    Proc Natl Acad Sci U S A. 2024;121:e2403808121.
    PubMed     Abstract available
    
    
    
49. FITZGERALD J
    US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2403758121.
    PubMed    
    
    
    
50. RAINS SA, Richards AS
    Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.
    Proc Natl Acad Sci U S A. 2024;121:e2409246121.
    PubMed    
    
    
    September 2024
51. SPONHOLTZ MR, Byrne PO, Lee AG, Ramamohan AR, et al
    Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.
    Proc Natl Acad Sci U S A. 2024;121:e2404250121.
    PubMed     Abstract available
    
    
    
52. WANG X, Dou Y, Hu J, Chan CH, et al
    Conserved moonlighting protein pyruvate dehydrogenase induces robust protection against Staphylococcus aureus infection.
    Proc Natl Acad Sci U S A. 2024;121:e2321939121.
    PubMed     Abstract available
    
    
    August 2024
53. ABBATE MF, Dupic T, Vigne E, Shahsavarian MA, et al
    Computational detection of antigen-specific B cell receptors following immunization.
    Proc Natl Acad Sci U S A. 2024;121:e2401058121.
    PubMed     Abstract available
    
    
    July 2024
54. HU Z, Lopez-Munoz AD, Kosik I, Li T, et al
    Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
    Proc Natl Acad Sci U S A. 2024;121:e2310421121.
    PubMed     Abstract available
    
    
    
55. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
    Mortality risk information and health-seeking behavior during an epidemic.
    Proc Natl Acad Sci U S A. 2024;121:e2315677121.
    PubMed     Abstract available
    
    
    June 2024
56. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed     Abstract available
    
    
    
57. WANG Y, Qu J, Xiong C, Chen B, et al
    Transdermal microarrayed electroporation for enhanced cancer immunotherapy based on DNA vaccination.
    Proc Natl Acad Sci U S A. 2024;121:e2322264121.
    PubMed     Abstract available
    
    
    
58. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed     Abstract available
    
    
    May 2024
59. WU C, Raheem IT, Nahas DD, Citron M, et al
    Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
    Proc Natl Acad Sci U S A. 2024;121:e2317230121.
    PubMed     Abstract available
    
    
    April 2024
60. CHEN G, Han Q, Li WX, Hai R, et al
    Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.
    Proc Natl Acad Sci U S A. 2024;121:e2321170121.
    PubMed     Abstract available
    
    
    
61. FREEDMAN AS, Sheen JK, Tsai S, Yao J, et al
    Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
    Proc Natl Acad Sci U S A. 2024;121:e2314357121.
    PubMed     Abstract available
    
    
    March 2024
62. CHANG S, Shin KS, Park B, Park S, et al
    Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
    Proc Natl Acad Sci U S A. 2024;121:e2313681121.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum